Gene targeting and the elucidation of mutations underlying inherited peroxisomal diseases have provided new insights in peroxisomal lipid metabolism in vivo. The work led to the identification of a novel peroxisomal β-oxidation pathway and established clearly that genes, which are required for efficient peroxisomal oxidation of fatty acids, at the same time are key regulators of PPARα function in vivo. The new mouse models may provide helpful tools in the search for unknown natural PPARα agonists and in screening for in vivo PPARα antagonists. J. Cell Biochem. Suppls. 30/31:158-167, 1998.
No takes yet. Share an insight, caveat, or question.
Udo Seedorf (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: